BeiGene cancer drug misses mark in Phase III study
Drug Discovery | News | 0 Comment | 20 Dec, 2019
China based BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innova...Read more
Takeda, Turnstone Biologics to develop novel viral immunotherapies
Drug Discovery | News | 0 Comment | 20 Dec, 2019
US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...Read more
European Commission approves Roche’s breast cancer drug
Drug Discovery | News | 0 Comment | 19 Dec, 2019
Roche has announced that the European Commission has approved Kadcyla® (trastuzumab emtansine) for the adjuvant (aft...Read more
Pfizer, Astellas' Xtandi Gets FDA nod
Drug Discovery | News | 0 Comment | 17 Dec, 2019
Pfizer and Japan based Astellas Pharma have announced that the U.S. Food and Drug Administration (FDA) has approved a su...Read more
AstraZeneca, Daiichi Sankyo’s trastuzumab shows promise in Phase II Trial
Drug Discovery | News | 0 Comment | 16 Dec, 2019
AstraZeneca and Daiichi Sankyo Company presented positive detailed data from the global pivotal Phase II single-arm DEST...Read more
Brii Biosciences expands focus to neurosciences
Drug Discovery | News | 0 Comment | 04 Dec, 2019
Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in Chi...Read more
Innovent, Eli Lilly presents co-developed cancer-fighting Tyvyt at CIIE 2019
Drug Discovery | News | 0 Comment | 02 Dec, 2019
Innovent Biologics, a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Ty...Read more
Chugai Pharma's study on satralizumab published in The New England Journal of Medicine
Drug Discovery | News | 0 Comment | 02 Dec, 2019
Chugai Pharmaceutical has announced that the "New England Journal of Medicine" (NEJM) online edition November 27 R...Read more
Astellas to treat men with metastatic castration-resistant prostate cancer in China
Drug Discovery | News | 0 Comment | 26 Nov, 2019
Astellas Pharma Inc., based in Tokyo, Japan has announced the China National Medical Products Administration ...Read more
Pfizer Unveils Positive Results for VIZIMPRO® as first-line monotherapy in NSCLC patients
Drug Discovery | News | 0 Comment | 26 Nov, 2019
Pfizer Inc. on 25th Nov 2019, announced the efficacy and tolerability results from the subgroup analysis of Asian patien...Read more
Merck presented Data on Tepotinib for NSCLC at ESMO Asia 2019
Drug Discovery | News | 0 Comment | 25 Nov, 2019
Merck, a leading science and technology company, on 25 Nov 2019, announced the presentation of multiple abstracts on tep...Read more
BeiGene receives its first FDA approval
Drug Discovery | News | 0 Comment | 18 Nov, 2019
BeiGene, Ltd., China, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative ...Read more
Yuhan Pharmaceuticals partners with Cyclica
Drug Discovery | News | 0 Comment | 13 Nov, 2019
South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo biotechnology c...Read more
China approves Alzheimer's drug
Drug Discovery | News | 0 Comment | 11 Nov, 2019
The State Food and Drug Administration of China (CFDA) has conditionally approved the application for the listing o...Read more
Samsung Biologics collaborates with Ichnos Sciences in derma space
Drug Discovery | News | 0 Comment | 06 Nov, 2019
South Korea headquartered Samsung Biologics has announced the signing of a long-term agreement with US based Ichnos Scie...Read more
EU approves BAVENCIO® (avelumab) Plus Axitinib to treat RCC
Drug Discovery | News | 0 Comment | 29 Oct, 2019
Merck and Pfizer Inc. on 29 Oct 2019, announced that the European Commission (EC) has approved BAVENCIO® (avelu...Read more
Biogen plans regulatory filing for Aducanumab for Alzheimer's
Drug Discovery | News | 0 Comment | 23 Oct, 2019
Biogen and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administrati...Read more
Takeda acquires license for celiac disease therapy
Drug Discovery | News | 0 Comment | 22 Oct, 2019
Japanese firm Takeda Pharmaceutical Company and US based COUR Pharmaceutical Development Company, Inc. have announ...Read more